The cyclization of (L-a-amino-d-adipyl)-L-cysteinyl-D-valine (ACV)1) to isopenicillin N is carried out by the enzyme isopenicillin N synthetase2.3). This enzyme which plays an important role in the secondary metabolism of Acremonium chrysogenum4-7)>, Penicillium chrysogenum 8,9) and some species of Streptomyces 7-12), may accept as substrate molecules similar to ACV in which the L-valine moiety has been replaced13- 14) .
Other changes in the molecular structure (the L-a-aminoadipyl moiety) are only tolerated to a certain extent15-17) and in most cases this implies a lack of cyclization18). However, recent studies19) have shown that P. chrysogenum and A. chrysogenum cyclases are able to accept as substrate peptides in which the L-a-aminoadipyl moiety has been replaced by phenylacetic acid. In the present work an attempt was made to cyclize the heteropeptide phenylacetyl-L-cysteinyl-D-valine using cell-free extracts of Streptomyces clavuligerus.
Materials and Methods

Materials
Phenylacetyl-L-cysteinyl-D-valine (PCV) was synthesized according to the methodology described by WOLFE and JOKINEN20) using phenylacetic acid instead of L-a-aminoadipic acid (Fig. 1) S. clavuligerus ATCC 27064 was maintained and grown as described by O'SULLIVAN et al.=21). Mycelium (250 ml of culture) was harvested by centrifugation at 10,000 x g for 5 minutes, washed four times by resuspension in sterile saline solution and centrifuged as before. The precipitated cells, resuspended in 25 ml of 50 mm Tris-HCl buffer (pH 7.5) containing 0.1 mm dithiothreitol (DTT) (TD buffer), were sonicated as previously described12) using a Branson Sonifier Cell Disruptor (B-12). The broken cell suspension was ultracentrifuged at 100,000 x g (Beckman L5-65B) for 90 minutes, treated with 0.2% (w/v) protamine sulfate and the clear extract precipitated with ammonium sulfate (30-80 saturation). The resulting precipitate was resuspended in 3 ml of TD buffer and applied to a Sephadex G-25, PD-10 column (Pharmacia). Aliquots of 1 ml were collected and assayed for cyclase activity. Fractions 4 and 5, containing maximal activity, were mixed and employed for the reaction. The extracts were stored frozen at -20°C.
Protein was measured by the method of LOWRY et al .12) . Cyclization activity was assayed by the method described by JENSEN et al.12), slightly modified. The reaction mixture contained 30 mm Tris-HCl buffer (pH 7.5), 0.5 mm FeSO4, 1 mm bis-LLD ACV or 3 mm bis PCV, 4 mm DTT, 3 mm Na-ascorbate and enzyme (10 mg of protein) in a final reaction volume of 0.5 ml. The reaction mixture was incubated at 25°C for 90 minutes and stopped by adding 0.5 ml of MeOH.
The formation of isopenicillin N and benzylpenicillin was measured by bioassay against M. luteus ATCC 9341 following the hole plate method23). Penicillin N and benzylpenicillin were used as standards. One unit of antibiotic (penicillin N or benzylpenicillin) gives a zone of inhibition equivalent to 1 ug or 1.58 jig of penicillin N or benzylpenicillin respectively with M. luteus ATCC 9341 as test organism.
Isopenicillin N from the reaction mixture was identified under the conditions described by JENSEN et a1.24). Benzylpenicillin, obtained by cyclization of PCV, was identified using a Perkin Elmer Chromatograph, Series 3B, with a LC-75 Spectrophotometric Detector and a Sigma 1013 Chromatography Data Station. A 30-cm 1Bondapack C-18 column (Waters Associates Inc.) and a mobile phase composed of 83 % (0.1 M sodium acetate -acetic acid, pH 4.5) and 17 % of acetonitrile were used. The column was eluted at 90 kg/cm using a flow rate of 2.0 ml/minute. The retention time of benzylpenicillin under these conditions was 12.3 minutes.
Results and Discussion
The cyclization of PCV using a preparation of isopenicillin N synthetase from S. clavuligerus leads to the formation of a molecule active against M. luteus ATCC 9341 and sensitive to (9-lactamase I from Bacillus cereus (Difco) ( Table 1 ). This product, in contrast to the isopenicillin N obtained from ACV, loses over 90 percent of its antibacterial activity when incubated with 2 I.U. of penicillin acylase (10 minutes, 30°C) (Table 1) . Furthermore, the antibiotic once extracted with amylacetate at pH 2.5, and after transferring to 50 mm phosphate buffer (pH 7.0), was identified by HPLC11) as benzylpenicillin. Fig. 2 shows that in the above cyclization conditions only 0.15 u/ml of benzyl-penicillin are produced, while in similar conditions, 40 u/ml of isopenicillin N (evaluated as penicillin N) were obtained (see Materials and Methods). This result, which implies a very low cyclization efficiency (not more than 0.01 % of the PCV is cyclized) supports the hypothesis of BALDWIN et al. 15) according to which the L-a-aminoadipic acid moiety plays an important role in the formation of the enzyme substrate complex. However, the ability of this enzyme to accept PCV as substrate appears conflict with other previous observations16) to the effect that isopenicillin N synthetase does not tolerate much of a change in the L-a-aminoadipyl moiety of the normal substrate (ACV) and although to some degree it accepts the removal of the terminal amino group or substitution of a CH, by a sulfur atom17), it does not tolerate any shortening of the side-chain even by one carbon16). This apparent discrepancy is accounted for by low efficiency of PCV cyclization. For the same reason, the hypothesis of BALDWIN et a1.15) concerning the minimal structural requirements of the N-acyl group may be accepted as valid although the side chain of PCV (phenylacetic acid) has more than six carbons and does not terminate in a carboxylgroup. Similar results to those described here have been reported by us19) and the Oxford group who demonstrated, by bioassay an mass spectral analysis, that isopenicillin N synthetase from A. chrysogenum is able to cyclize to the corresponding antibiotic, peptides in which the L-a-aminoadipyl moiety has been changed by phenylacetyl, phenoxyacetyl and other related molecules25). The isolation of mutants in which the cyclase has a wider substrate specificity could be important for the fermentation industry in the future. 
